PRIMARY SJOGREN'S SYNDROME
Clinical trials for PRIMARY SJOGREN'S SYNDROME explained in plain language.
Never miss a new study
Get alerted when new PRIMARY SJOGREN'S SYNDROME trials appear
Sign up with your email to follow new studies for PRIMARY SJOGREN'S SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
First-of-its-Kind cell therapy trial targets Hard-to-Treat autoimmune illnesses
Disease control Recruiting nowThis early-stage study is testing the safety of a new cell therapy called OL-CD19-GDT for adults with severe autoimmune diseases that haven't responded to other treatments. The therapy involves modifying a patient's own immune cells to potentially reset the immune system and redu…
Matched conditions: PRIMARY SJOGREN'S SYNDROME
Phase: PHASE1 • Sponsor: Beijing GoBroad Hospital • Aim: Disease control
Last updated Apr 04, 2026 05:20 UTC
-
New hope for kids with untreatable autoimmune diseases
Disease control Recruiting nowThis is an early-stage study testing a new type of cell therapy called BCMA/CD70 CAR-T for children with severe rheumatic diseases that have not responded to standard treatments. The trial aims to see if this therapy is safe and can reduce disease activity in conditions like juve…
Matched conditions: PRIMARY SJOGREN'S SYNDROME
Phase: PHASE1 • Sponsor: Chongqing Precision Biotech Co., Ltd • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC